CHICAGO – The postoperative addition of nivolumab (Opdivo) to chemoradiotherapy (CRT) extended disease-free survival (DFS) in ...

NIVOPOSTOP trial data demonstrate a reduction in the risk of recurrence or death with adjuvant nivolumab combined with ...

Libtayo (cemiplimab) was cleared in 2018 for treating advanced CSCC in patients who are not candidates for curative surgery ...

Adjuvant Opdivo, cisplatin and radiotherapy improved DFS vs other treatment among those with locally advanced squamous cell ...

Adding nivolumab to adjuvant CRT improved DFS in patients with locally advanced head and neck squamous cell carcinoma at high risk of relapse.

"These long-term results continue to support [pembrolizumab's] use as a standard of care for patients at increased risk of ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

In certain disease sites (eg, lymphoma and early-stage endometrial cancer), adjuvant radiation therapy is found to benefit event-free survival but not necessarily overall survival. In this ...

Study authors examined the diagnostic utility of radiologic imaging for patients with high-risk cutaneous squamous cell carcinoma.

However, current adjuvant treatments are based on ionizing radiation, which brings radiation-induced damage and amplifies the risk of death. Here we explore the feasibility of using non-ionizing light ...

A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule ...